Cite
HARVARD Citation
Watanabe, T. et al. (2017). Predictors of treatment efficacy and ALT non‐normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2. Journal of medical virology. 89 (9), pp. 1567-1573. [Online].